Prevalence of Non-motor Symptoms in Parkinson’s Disease: A Study from South India
Journal Title: Turkish Journal of Neurology - Year 2021, Vol 27, Issue 1
Abstract
Objective: Non-motor symptoms (NMS) play a vital role in managing Parkinson’s disease (PD) and have become the leading cause of deterioration of quality of life with the progression of the disease. The aim of the present study was to investigate the prevalence of NMS in PD with disease duration. Materials and Methods: We selected 75 patients with PD prospectively and all patients were diagnosed according to the United Kingdom PD Brain Bank criteria. All patients were trichotomized based on disease duration (≤4 years, 5-8 years and ≥9 years). The NMS screening questionnaire comprising 30 items was completed by all patients. Results: Out of 75 patients, men constituted 82.6%, the mean age was 59.2±1.51 (range, 45-69) years. The overall prevalence of NMS was 100%. Among the patients with a disease duration of ≤4 years, 5-8 years, and ≥9 years, gastrointestinal symptoms were observed in 38%, 48%, and 86.2%; cardiovascular dysfunction in 47.6%, 44%, and 82.7%; urinary problems in 38%, 40%, and 72.4%; poor sexual performance in 42.8%, 40%, and 79.3%; sleep disturbance in 38%, 36%, and 75.8%; anxiety in 33.3%, 40%, and 79.3%; hallucinations in 33.3%, 36%, and 72.4%; and cognition problems in 38%, 32%, and 72.4%, respectively. Significantly higher prevalences of gastrointestinal symptoms (p=0.006), cardiovascular dysfunctions (p=0.007), urinary problems (p=0.03), poor sexual performance (p=0.007), sleep disturbances (p=0.007), anxiety (p=0.007), hallucinations (p=0.03), and cognitive problems (p=0.007) were noted in patients with ≥9 years disease duration. Conclusion: Our study established that 100% of patients with PD had at least one NMS and there was a higher prevalence of NMS among those with disease duration more than 9 years.
Authors and Affiliations
Jay Ray Chaudhuri, Kandadai Rukmini Mridula, Vcs Srinivasarao Bandaru
Keywords
Related Articles
- EP ID EP693454
- DOI 10.4274/tnd.2021.52993
- Views 137
- Downloads 0
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...
Seizures with Autonomic Symptoms and Sudden Unexpected Death in Epilepsy (SUDEP)
The autonomic nervous system, formerly the vegetative nervous system, is a division of the peripheral nervous system that supplies smooth muscle and glands, and thus influences the function of internal organs. The hypoth...
A Male Patient Showing Abnormal Gait and Dysarthria with Psychotic Symptoms
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal-recessive and neurodegenerative disorder associated with progressive motor impairment and mental deterioration. The diagnosis of PKAN consists o...
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
no summary
Quality of Life in Patients with Drug Resistant Epilepsy
Objective: Quality of life (QOL) is considered the main outcome in epilepsy trials, but in developing countries such as India, data available regarding QOL in drug-resistant epilepsy (DRE) are scarce. The present study w...